WELCOME TO

Specialist Communications for Life Sciences
Zyme Communications provides PR and marketing services for the life science sector. We support companies to raise their profile, build corporate value and generate interest from commercial leads, investors and partners.

Our
Services
Focused on supporting life science companies to raise their profile, build corporate value, and generate interest, the services we provide include:
PR & Media
- Press releases
- Article writing and placement
- Media interviews
- Messaging
- Copy writing
- Social media
- Media training
- Events
Marketing
- Conference, event and trade show support
- Marketing literature
- Market research
- Campaign development
- Advertising
- Sponsorship
- Product launches
Design & Branding
- Website design and development
- Print collateral development
- Identity and logo creation
- Brand strategy
- Presentation development
- Video production
Investor Relations
- Business plan development
- Presentation development
- PR targeting the life science trade press read by investors

The
Team
An experienced senior team of specialists in life science communications, with expertise gained in-house and agency side, offering the flexibility to support both early-stage companies and large multinationals.
EVENTS
-
Investival Showcase USA
-
OBN BioTrinity 2026
-
PEGS Boston
-
BioBeat 2026
PRISM ALS: New stem cell models could transform research into treatments for MND/ALS
PRISM ALS is a new global initiative designed to accelerate the discovery of effective treatments for ALS/MND by improving access to specially grown, patient-derived stem cell models that better reflect [...]
Semarion secures $3.8 million to scale next-generation cell assay technology and accelerate pharma adoption
Funding supports expansion of manufacturing and commercial capacity for SemaCyte microcarrier platform Cambridge, UK, 31 March 2026: Semarion, a University of Cambridge spin-out company from the Cavendish Laboratory combining materials [...]
Broken String Biosciences Rebrands to Reflect Strategic Evolution as Demand Grows for Unbiased Genome-wide Off-target Analysis
Rebrand follows appointment of new leadership as company drives commercialization of INDUCE-seq platform to address regulatory gaps in off-target reporting for gene editing programs Cambridge, UK, 31 March 2026 – [...]




















